Wells Fargo Maintains Overweight on Abbott Laboratories, Raises Price Target to $119

Benzinga · 2d ago
Wells Fargo analyst Larry Biegelsen maintains Abbott Laboratories (NYSE:ABT) with a Overweight and raises the price target from $112 to $119.